1 / 3

Antiviral Drugs Market 2022 by Manufacturers, Regions, Type and Application

The global antiviral drugs market is presently valued at USD 35.65 billion and is anticipated to register a CAGR of 5.15% over the forecast duration 2022-2030, thereby accumulating USD 55.17 billion by the end of the analysis timeline.

wemresearch
Download Presentation

Antiviral Drugs Market 2022 by Manufacturers, Regions, Type and Application

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Antiviral Drugs Market 2022 Key Players Data and Industry Analysis. The global antiviral drugs market is presently valued at USD 35.65 billion and is anticipated to register a CAGR of 5.15% over the forecast duration 2022-2030, thereby accumulating USD 55.17 billion by the end of the analysis timeline. Antiviral medications are used to treat viral illnesses such the flu, hepatitis, and the human immunodeficiency virus (HIV). A variety of viruses can be treated with broad-spectrum antiviral medications. Over the forecast period, the market expansion is anticipated to be driven by the rising acceptance of medications for the treatment of viral infections. For instance, the pharmaceutical company GlaxoSmithKline Plc announced in March 2019 that the National Medical Products Administration had approved Viread (tenofovir disoproxil fumarate), an oral antiviral drug for the treatment of chronic hepatitis B, for its updated safety data regarding the treatment of chronic hepatitis B in pregnant patients. The class of medications known as antiviral pharmaceuticals is used to treat viral illnesses like hepatitis, HIV, and influenza, among others. These medications can be prescribed as tablets, liquids, injectable solutions, and powders for inhalation. Antiviral medications are used to get rid of viruses that cause illness from the body. Various antiviral drug classes, including protease inhibitors, reverse transcriptase inhibitors (NRTIs and NNRTIs), neuraminidase inhibitors, and DNA polymerase inhibitors, are offered on the market. Antiviral Drugs Market- Segmental Analysis By Drug class •DNA polymerase inhibitors •Reverse transcriptase inhibitors

  2. •Protease inhibitors •Neuraminidase inhibitors •Others The reverse transcriptase inhibitors segment is expected to register notable gains over the analysis timeline owing to rising diagnosis and treatment rate pertaining to HIV. •By Indication •Influenza •HIV AIDS •Hepatitis •Herpes simplex virus (HSV) •Coronavirus infection •Others The HIV AIDS segment presently dominates the market and is anticipated to showcase similar expansion trends in the ensuing years. This is credited to rising prevalence of HIV and absence of effective vaccines against the disease. By Type •Branded •Generic The generic segment is poised to capture a high revenue share over 2022-2030 owing to cost effectiveness and easy availability of generic drugs. By Age group •Adult •Pediatric •Geriatric The geriatric segment is slated to grow substantially over the stipulated timeline as the elderly people are highly prone to various viral diseases and hence require anti-viral drugs to a massive extend. Get Free Sample:- https://wemarketresearch.com/sample-request/antiviral-drugs-market/56/ Top Key Players:- •AbbVie Inc •Merck & Co •GlaxoSmithKline plc •Aurobindo Pharma Limited •Johnson & Johnson •Sun Pharmaceutical Industries Ltd •Cipla, Inc •Mylan N V •Bristol-Myers Squibb •F. Hoffmann-La Roche Ltd

  3. •Abbott Laboratories •AstraZeneca plc •AbbVie Inc •Schering-Plough Corporation •Dr. Reddy’s Laboratories Ltd •Novartis AG, •Pfizer Inc •Sanofi. Interested in purchasing this Report? Click here:- https://wemarketresearch.com/purchase/antiviral- drugs-market/56/?license=single Frequently Asked Questions (FAQ): 1.How big is the antiviral drugs market? 2.What is the antiviral drugs market growth? 3.Which segment accounted for the largest antiviral drugs market share? 4.Who are the key players in the antiviral drugs market? 5.What are the factors driving the antiviral drugs market? About We Market Research WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets. Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. WE MARKET RESEARCH is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients. Contact Us: We Market Research Phone: +1(929)-450-2887 Email: sales@wemarketresearch.com Web: https://wemarketresearch.com/

More Related